Marshall Wace LLP Buys 309,335 Shares of Cardinal Health, Inc. $CAH

Marshall Wace LLP raised its stake in Cardinal Health, Inc. (NYSE:CAH) by 19.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,930,967 shares of the company’s stock after purchasing an additional 309,335 shares during the period. Marshall Wace LLP owned 0.81% of Cardinal Health worth $324,402,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in CAH. Greykasell Wealth Strategies Inc. bought a new stake in Cardinal Health in the 1st quarter valued at about $26,000. Jones Financial Companies Lllp increased its holdings in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares in the last quarter. Atlantic Edge Private Wealth Management LLC raised its position in shares of Cardinal Health by 75.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares during the period. Vermillion & White Wealth Management Group LLC lifted its holdings in shares of Cardinal Health by 55.0% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after purchasing an additional 71 shares in the last quarter. Finally, NewSquare Capital LLC grew its position in Cardinal Health by 100.0% in the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after purchasing an additional 107 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

NYSE CAH opened at $198.97 on Friday. The company has a market capitalization of $47.27 billion, a PE ratio of 30.01, a price-to-earnings-growth ratio of 1.45 and a beta of 0.63. Cardinal Health, Inc. has a 52-week low of $114.60 and a 52-week high of $214.93. The company has a 50-day simple moving average of $181.69 and a 200 day simple moving average of $164.74.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company’s revenue was up 22.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. The ex-dividend date is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio is presently 30.77%.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Jefferies Financial Group set a $220.00 price objective on shares of Cardinal Health and gave the stock a “buy” rating in a report on Monday, November 3rd. UBS Group upped their target price on shares of Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a report on Friday, October 31st. Deutsche Bank Aktiengesellschaft raised their price target on shares of Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research report on Tuesday, November 18th. Mizuho boosted their price objective on Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a report on Monday, November 3rd. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $206.57.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.